Picard Medical, Inc. (PMI)
NYSEAMERICAN: PMI · Real-Time Price · USD
3.640
+0.210 (6.12%)
Aug 10, 2026, 4:00 PM EDT - Market closed
Picard Medical Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Cash & Equivalents | 0.12 | 7.45 | 0.1 | 0.24 | 0.15 |
Cash & Short-Term Investments | 0.12 | 7.45 | 0.1 | 0.24 | 0.15 |
Cash Growth | -82.41% | 7661.46% | -60.66% | 60.53% | - |
Accounts Receivable | 0.6 | 0.62 | 0.51 | 0.63 | 0.88 |
Inventory | 7.45 | 7.3 | 8.12 | 6.89 | 7.33 |
Other Current Assets | 1.35 | 5.35 | 1.07 | 1 | 3.76 |
Total Current Assets | 9.51 | 20.73 | 9.79 | 8.76 | 12.12 |
Net Property, Plant & Equipment | 0.61 | 0.7 | 1.1 | 1.31 | 1.93 |
Other Intangible Assets | 0.49 | 0.51 | 0.6 | 0.68 | 0.77 |
Goodwill | 0.62 | 0.62 | 0.62 | 0.62 | 0.62 |
Total Assets | 11.22 | 22.55 | 12.11 | 11.37 | 15.44 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Accounts Payable | 2.71 | 2.08 | 5.29 | 3.08 | 1.39 |
Accrued Expenses | 1.98 | 1.86 | 2.86 | 1.76 | 0.72 |
Short-Term Debt | 2.86 | 6.45 | 5.15 | 4.06 | 0.62 |
Current Portion of Long-Term Debt | - | - | 14.83 | - | - |
Current Portion of Leases | 0.41 | 0.46 | 0.43 | 0.31 | 0.27 |
Other Current Liabilities | 4.7 | 7.84 | 6.76 | - | - |
Total Current Liabilities | 12.66 | 18.7 | 35.33 | 9.21 | 3 |
Long-Term Debt | - | - | - | 4.28 | - |
Long-Term Leases | 0.01 | 0.06 | 0.52 | 0.76 | 1.07 |
Other Long-Term Liabilities | - | - | - | 0.67 | - |
Total Long-Term Liabilities | 0.01 | 0.06 | 0.52 | 5.71 | 1.07 |
Total Liabilities | 12.67 | 18.76 | 35.84 | 14.93 | 4.07 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Common Stock | 0.01 | 0.01 | 0 | 0 | - |
Additional Paid-in Capital | 82.76 | 80.4 | 5.56 | 4.68 | 3.92 |
Accumulated Other Comprehensive Income | 0.25 | 0.23 | 0.28 | 0.29 | 0.4 |
Retained Earnings | -84.46 | -76.84 | -49.84 | -28.79 | -13.22 |
Total Common Shareholders' Equity | -1.45 | 3.79 | -44 | -23.82 | -8.9 |
Minority Interest | - | - | 20.27 | 20.27 | 20.27 |
Shareholders' Equity | -1.45 | 3.79 | -23.74 | -3.55 | 11.37 |
Total Liabilities & Equity | 11.22 | 22.55 | 12.11 | 11.37 | 15.44 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Total Debt | 3.27 | 6.98 | 20.93 | 9.41 | 1.96 |
Net Cash (Debt) | -3.15 | 0.48 | -20.83 | -9.17 | -1.81 |
Net Cash Growth | - | - | - | - | - |
Net Cash Per Share | -2.98 | 0.66 | -131.12 | -57.70 | -16.16 |
Book Value | -1.45 | 3.79 | -44 | -23.82 | -8.9 |
Book Value Per Share | -1.37 | 5.23 | -276.96 | -149.91 | -79.55 |
Tangible Book Value | -2.55 | 2.67 | -45.21 | -25.12 | -10.28 |
Tangible Book Value Per Share | -2.41 | 3.68 | -284.58 | -158.09 | -91.95 |